| Controls (n = 20) | Patients (n = 13) | P |
---|---|---|---|
LV-EF (%) | 66 ± 4 | 63 ± 7 | 0.60 |
LV-EDV (ml) | 109 ± 28 | 111 ± 36 | 1 |
LV-ESV (ml) | 37 ± 13 | 43 ± 24 | 0.82 |
LV-SV | 71 ± 16 | 67 ± 12 | 0.55 |
LV-EDD | 45 ± 5 | 46 ± 4 | 1 |
LA (cm2) | 20 ± 4 | 17 ± 3 | 0.02 |
IVS (mm) | 10 ± 2 | 9 ± 1 | 0.35 |
PA (mm) | 24 ± 4 | 22 ± 3 | 0.08 |
LV mass (g) | 76 ± 18 | 85 ± 21 | 0.41 |
LGE per patient | - | 3 (23Â %) | Â |
 Epicardial | - | 1 (8 %) |  |
 Intramural | - | 2 (15 %) |  |
 Transmural | - | 1 (8 %) |  |
 Subendocardial | - | - |  |
% LV mass | - | 6.2 | Â |
Native T1 (ms) | 962 (947–987) | 1002 (976–1015) | 0.03 |
Post contrast T1 (ms) | 526 (508–553) | 507 (479–539) | 0.16 |
ECV (%) | 25 (24–27) | 26 (25–29) | 0.24 |
T2 (ms) | 49 (48–51) | 51 (49–53) | 0.02 |